15 November 2019
The Royal National Institute of Blind People (RNIB) has partnered with Sight Concern Bedfordshire to jointly fund an eye clinic liaison officer (ECLO) service at Luton & Dunstable Hospital.
The role of the ECLO, which had previously been solely funded by Sight Concern Bedfordshire, involves providing support and advice to blind and partially sighted patients.
RNIB partnerships and development manager for East Midlands & East of England, Jacqueline Price, said was it was “great news” that a sustainable future was secured for the eye clinic liaison officer service at the hospital. “It can be an overwhelming experience being told you are going to lose your sight. That feeling is compounded if people have to deal with it alone,” she explained.
ECLO at Luton and Dunstable Hospital, Mark Chapman said that he was pleased to now be working for the RNIB. “This is a hugely positive collaboration between the two organisations to provide a sustainable service to those people I meet in the eye clinic who need emotional support and advice having just received a life changing sight loss diagnosis,” he shared.
The role of the ECLO, which had previously been solely funded by Sight Concern Bedfordshire, involves providing support and advice to blind and partially sighted patients.
RNIB partnerships and development manager for East Midlands & East of England, Jacqueline Price, said was it was “great news” that a sustainable future was secured for the eye clinic liaison officer service at the hospital. “It can be an overwhelming experience being told you are going to lose your sight. That feeling is compounded if people have to deal with it alone,” she explained.
ECLO at Luton and Dunstable Hospital, Mark Chapman said that he was pleased to now be working for the RNIB. “This is a hugely positive collaboration between the two organisations to provide a sustainable service to those people I meet in the eye clinic who need emotional support and advice having just received a life changing sight loss diagnosis,” he shared.
Comments (0)
You must be logged in to join the discussion. Log in